In 2021, the global Oncology-based In-vivo CRO Market was estimated to be worth around $1 billion. With a projected CAGR of 10.9% over the next ten years, the market is expected to be worth nearly US$ 2.9 billion by the end of 2033. By 2033, the absolute dollar opportunity in the Oncology-based In-vivo CRO Market …
Continue reading “Oncology-Based In-vivo CRO Market is likely to US$ 2.9 by the end of 2033”